Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can E-Cigs help smokers in lung screening kick the habit? small study tests the idea

NCT ID NCT06472869

Completed Disease control Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study looked at whether giving free e-cigarettes to smokers who hadn't quit after lung cancer screening could help them smoke fewer regular cigarettes. Fifteen people who smoked at least 5 cigarettes a day were given NJOY ACE e-cigarettes for 4 weeks and asked to switch. The study measured how many enrolled, stayed in the trial, and how their smoking changed. It's a very early, small test to see if this approach is worth studying further.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
NJOY ACE e-cigarette with 5% nicotine
What this could lead to
If successful, this could point toward a way to help smokers who haven't quit reduce their cigarette use, potentially lowering health risks.
What could go wrong
This is a very small pilot study (15 people) with no control group, so results may not apply broadly. E-cigarettes have their own health risks and are not FDA-approved for smoking cessation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ELECTRONIC CIGARETTE USE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cigarette Smoking nicotine dependence Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ELECTRONIC CIGARETTE USE NICOTINE DEPENDENCE SMOKING ( CIGARETTE)

Contacts and locations

Locations

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.